ICON Public Limited Company (ICLR)
NASDAQ: ICLR · Real-Time Price · USD
186.58
-3.35 (-1.76%)
At close: Dec 12, 2025, 4:00 PM EST
188.28
+1.70 (0.91%)
After-hours: Dec 12, 2025, 7:11 PM EST
ICLR Employees
ICON Public Limited Company had 41,900 employees as of December 31, 2024. The number of employees increased by 800 or 1.95% compared to the previous year.
Employees
41,900
Change (1Y)
800
Growth (1Y)
1.95%
Revenue / Employee
$193,380
Profits / Employee
$14,307
Market Cap
14.25B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 41,900 | 800 | 1.95% |
| Dec 31, 2023 | 41,100 | 0 | - |
| Dec 31, 2022 | 41,100 | 2,770 | 7.23% |
| Dec 31, 2021 | 38,330 | 22,600 | 143.67% |
| Dec 31, 2020 | 15,730 | 1,080 | 7.37% |
| Dec 31, 2019 | 14,650 | 980 | 7.17% |
| Dec 31, 2018 | 13,670 | 420 | 3.17% |
| Dec 31, 2017 | 13,250 | 750 | 6.00% |
| Dec 31, 2016 | 12,500 | 600 | 5.04% |
| Dec 31, 2015 | 11,900 | 1,300 | 12.26% |
| Dec 31, 2014 | 10,600 | 300 | 2.91% |
| Dec 31, 2013 | 10,300 | 800 | 8.42% |
| Dec 31, 2012 | 9,500 | 1,030 | 12.16% |
| Dec 31, 2011 | 8,470 | 735 | 9.50% |
| Dec 31, 2010 | 7,735 | 565 | 7.88% |
| Dec 31, 2009 | 7,170 | 195 | 2.80% |
| Dec 31, 2008 | 6,975 | 1,365 | 24.33% |
| Dec 31, 2007 | 5,610 | 1,320 | 30.77% |
| Dec 31, 2006 | 4,290 | 1,254 | 41.30% |
| Dec 31, 2005 | 3,036 | 604 | 24.84% |
| May 31, 2004 | 2,432 | 152 | 6.67% |
| May 31, 2003 | 2,280 | 643 | 39.28% |
| May 31, 2002 | 1,637 | 375 | 29.71% |
| May 31, 2001 | 1,262 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ICLR News
- 3 days ago - ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive - Business Wire
- 10 days ago - ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions - Business Wire
- 22 days ago - ICON Public Limited Company (ICLR) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 4 weeks ago - ICON plc to Present at the Jefferies London Healthcare Conference - Business Wire
- 5 weeks ago - Invesco International Small-Mid Company Fund Q3 2025 Top Contributors And Detractors - Seeking Alpha
- 7 weeks ago - ICON Public Limited Company (ICLR) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - ICON Reports Third Quarter 2025 Results - Business Wire
- 7 weeks ago - ICON: Solid Fundamentals Trump Regulatory Headwinds - Seeking Alpha